vimarsana.com
Home
Live Updates
Transgene's Combined General Meeting of May 25, 2022 : vimar
Transgene's Combined General Meeting of May 25, 2022 : vimar
Transgene's Combined General Meeting of May 25, 2022
Regulatory News: The Combined Ordinary and Extraordinary General Meeting of Transgene's (Paris:TNG) shareholders was held today (May 25, 2022) at 10:00 a.m. at the Company's headquarters (400 boulevard
Related Keywords
Milan ,
Lombardia ,
Italy ,
United States ,
Illkirch Graffenstaden ,
Alsace ,
France ,
Andernach ,
Rheinland Pfalz ,
Germany ,
French ,
Lucie Larguier ,
Sandrine Flory ,
Ben Brahim ,
Alessandro Riva ,
Marie Landel ,
Sylvie Berrebi ,
Laurence Espinasse ,
Philippe Archinard ,
Transgene Euronext ,
Centre Sud Montpellier ,
European Society Of Medical Oncology ,
Twitter ,
European Commission Conticanet ,
Claude Bernard University In Lyon ,
Astrazeneca ,
French National Cancer Institute ,
Scientific Panel For Health ,
French National Academy Of Medicine ,
European Organization For Research ,
Cell Gene Therapy At Gilead Sciences ,
Global Head Of Oncology Development ,
Ichnos Sciences ,
Ernst Young ,
Corporate Communications ,
Affairs At Novartis Pharmaceuticals ,
Life Sciences ,
French Sarcoma Group ,
University Of Milan ,
Regulatory News ,
Combined Ordinary ,
Extraordinary General Meeting ,
Andernach Parc ,
Hedi Ben Brahim ,
Combined General Meeting ,
Jean Yves Blay ,
Board Members ,
Statutory Auditor ,
Chief Executive Officer ,
Hedi Ben ,
Honorary Chairman ,
Investors General ,
Intima Bioscience ,
Executive Vice President ,
Global Head ,
Oncology Therapeutics ,
Cell Gene Therapy ,
Gilead Sciences ,
Kite Pharma ,
Oncology Development ,
Medical Affairs ,
Novartis Oncology ,
Yves Blay ,
Medical Oncology ,
General Director ,
Claude Bernard University ,
French National Cancer ,
European Organization ,
French Sarcoma ,
European Society ,
Scientific Panel ,
European Commission ,
French National Academy ,
Legal Director ,
Mission Director ,
Professional Lawyer ,
Business Law ,
Centre Sud ,
Artificial Intelligence ,
Risk Factors ,
Universal Registration Document ,
Transgene ,
Combined ,
Eneral ,
Meeting ,
022 ,